Evaluation of Infectious Complications and Their Causative Agents in Pediatric Cancer Patients: A Prospective Single-center Cohort Study

OpenAlex English

Objective: This study aimed to evaluate the epidemiological, microbiological, clinical characteristics of the patients followed up with different types of underlying hematologic malignancies and solid tumors.Method: This cohort study included patients with pediatric malignancy.Eighty-eight patients who were followed up for two years were included.The number of days from the first diagnosis, recurrent infectious episodes, number of days with fever, presence of neutropenia and nonneutropenic episodes, chemotherapy regimens, antimicrobial agents, blood and urinary tract culture samples were recorded.Results: A total of 149 infectious episodes were observed.The median age was 5.08 years.The mean age was 9.02±5.17years in patients who had no infectious episodes during the follow-up and 5.70±4.60 years in patients with two and more infectious episodes and was significantly lower (p=0.024).In total, 264 microbial cultures were retrieved from different locations during these infectious episodes.Regarding all the cultures, 27% of blood cultures and 9% of urinary tract cultures were positive.The most commonly isolated microorganism were Grampositive bacteria (n=23, 57.5%).Conclusion: Younger children with cancer are at higher risk of infection complications compared to children of older ages.Children with hematologic malignancies are more likely to develop a neutropenic fever during the consolidation and induction periods.Regarding the high rate of FUO in our study, more attempts to increase microbiological diagnosis in this patient population.